Metro Inc. (FRA:62M)
| Market Cap | 11.43B -20.7% |
| Revenue (ttm) | 13.74B +3.8% |
| Net Income | 609.31M +2.4% |
| EPS | 2.80 +5.6% |
| Shares Out | n/a |
| PE Ratio | 18.76 |
| Forward PE | 16.68 |
| Dividend | 0.96 (1.77%) |
| Ex-Dividend Date | May 13, 2026 |
| Volume | n/a |
| Open | 54.00 |
| Previous Close | 54.50 |
| Day's Range | 54.00 - 54.00 |
| 52-Week Range | 54.00 - 68.50 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |
About Metro
Metro Inc., through its subsidiaries, operates as a retailer, franchisor, distributor, and manufacturer in the food and pharmaceutical sectors in Canada. The company operates supermarkets, discount stores, neighbourhood stores, specialized stores, and pharmacies that provide fresh and grocery products, baked goods, prepared food products, meats, dairy products, fruits and vegetables, frozen food products, bakery products, prepared meals, delicatessen items, fruits and vegetables, frozen products and pastries. It also manufactures ready-to-eat m... [Read more]
Financial Performance
In fiscal year 2025, Metro's revenue was 22.01 billion, an increase of 3.71% compared to the previous year's 21.22 billion. Earnings were 1.02 billion, an increase of 9.50%.
Financial numbers in CAD Financial StatementsNews
Metro price target lowered to C$106 from C$113 at TD Securities
TD Securities lowered the firm’s price target on Metro (MTRAF) to C$106 from C$113 and keeps a Buy rating on the shares.
Metro price target lowered to C$97 from C$99 at Desjardins
Desjardins lowered the firm’s price target on Metro (MTRAF) to C$97 from C$99 and keeps a Hold rating on the shares.
Metro price target lowered to C$105 from C$110 at BMO Capital
BMO Capital analyst Etienne Ricard lowered the firm’s price target on Metro (MTRAF) to C$105 from C$110 and keeps an Outperform rating on the shares.
Metro price target lowered to C$96 from C$103 at Scotiabank
Scotiabank lowered the firm’s price target on Metro (MTRAF) to C$96 from C$103 and keeps a Sector Perform rating on the shares.
Metro Earnings Call Transcript: Q2 2026
Q2 saw 4.1% sales growth to CAD 5.1B, with strong pharmacy and discount banner performance, and adjusted EPS up 8.8%. Gross margin improved, online sales rose nearly 20%, and a Québec strike is expected to impact Q3.
Metro Earnings release: Q2 2026
Metro released its Q2 2026 earnings on April 22, 2026, summarizing the period's financial results.
Metro price target lowered to C$112 from C$113 at RBC Capital
RBC Capital lowered the firm’s price target on Metro (MTRAF) to C$112 from C$113 and keeps a Sector Perform rating on the shares.
Metro price target lowered to C$110 from C$115 at BMO Capital
BMO Capital analyst Etienne Ricard lowered the firm’s price target on Metro (MTRAF) to C$110 from C$115 and keeps an Outperform rating on the shares.
Metro price target lowered to C$103 from C$110 at Scotiabank
Scotiabank lowered the firm’s price target on Metro (MTRAF) to C$103 from C$110 and keeps an Outperform rating on the shares.
Metro price target lowered to C$113 from C$118 at TD Securities
TD Securities lowered the firm’s price target on Metro (MTRAF) to C$113 from C$118 and keeps a Buy rating on the shares.
Metro price target lowered to C$113 from C$118 at TD Securities
TD Securities analyst Michael Van Aelst lowered the firm’s price target on Metro (MTRAF) to C$113 from C$118 and keeps a Buy rating on the shares.
Metro Earnings Call Transcript: Q1 2026
Q1 saw 3.3% sales growth and 5.5% adjusted EPS growth, despite a costly freezer disruption. Food and pharmacy segments both posted positive same-store sales, with discount and online channels outperforming. Dividend was raised 10.1% and share buybacks continued.
Metro Earnings release: Q1 2026
Metro released its Q1 2026 earnings on January 27, 2026, summarizing the period's financial results.
Metro Earnings Call Transcript: Q4 2025
Q4 saw 3.4% sales growth and 8.6% higher adjusted net earnings, despite a CAD 22.5 million after-tax impact from a Toronto freezer shutdown. Discount and pharmacy segments led growth, with strong online and private label performance. FY 2026 guidance includes higher CapEx and continued store expansion.
Metro Earnings release: Q4 2025
Metro released its Q4 2025 earnings on November 19, 2025, summarizing the period's financial results.
Metro Earnings Call Transcript: Q3 2025
Q3 saw 3.3% sales growth, 5.7% EBITDA growth, and a 12.6% rise in adjusted EPS, with strong pharmacy and discount banner performance. Gross margin and productivity improved, while inflation and tariffs remain key risks. Online sales and store expansions contributed to growth.
Metro Earnings release: Q3 2025
Metro released its Q3 2025 earnings on August 13, 2025, summarizing the period's financial results.